Di(2-ethylhexyl) phthalate (DEHP) is known for its endocrine disrupting properties. We previously 36 demonstrated that prenatal DEHP exposure is associated with decreased progesterone levels and 37 testosterone/estradiol ratio in the cord blood. However, evidence of the effects of prenatal DEHP 38 exposure on adrenal androgen and glucocorticoids in infants is scarce. Thus, the objectives of this 39 study were to investigate the association between prenatal DEHP exposure and adrenal androgen and 40 glucocorticoids, and to discuss its effects on steroid hormone profiles in infants. This is part of a birth 41 cohort study: The Hokkaido Study on Environment and Children's Health, Sapporo Cohort. Among 42 the 514 participants, 202 mother-infant pairs with available data on maternal mono(2-ethylhexyl) 43 phthalate (MEHP), adrenal androgen (dehydroepiandrostenedione [DHEA] and androstenedione) and 44 glucocorticoid (cortisol and cortisone) cord blood levels were included in this study. After adjusting 45 for potential confounders, a linear regression analysis showed that maternal MEHP levels were 46 associated with reduced cortisol and cortisone levels and glucocorticoid/adrenal androgen ratio, 47 whereas increased DHEA levels and DHEA/androstenedione ratio. In a quartile model, when 48 comparing the adjusted least square means in the 4 th quartile of MEHP with those in the 1 st quartile, 49 cortisol and cortisone levels and glucocorticoid/adrenal androgen ratio decreased, whereas 50 DHEA/androstenedione and cortisol/cortisone ratios increased. Significant p-value trends for cortisol 51 and cortisone levels, cortisol/cortisone ratio, and glucocorticoid/adrenal androgen ratio were observed. 52
Introduction 86
Phthalate diesters (phthalates) have been used as plasticizers for various plastic products, including 87 toys, food containers, furniture, personal care products, medical devices, and housing materials. 88 According to a report from the Japan Plasticizer Industry Association and Ministry of Economy, Trade 89 and Industry in 2012, di(2-ethylhexyl) phthalate (DEHP) constitutes >50% of the phthalates used in 90 production in Japan. Phthalates are not chemically bonded to polyvinyl chloride in plastic products; 91 thus, they can leach into the air, dust, foodstuffs, and other materials. Consequently, humans are 92 constantly exposed to phthalates, and biomonitoring studies have demonstrated the widespread 93 exposure of the general population to these chemicals (Ait Bamai et al., 2015; Fromme et al., 2007; 94 Jensen et al., 2015; Koch et al., 2004; Wittassek et al., 2007) . 95 DEHP is a potential endocrine-disrupting chemical, and multiple adverse effects on human 96 health due to DEHP exposure in early life were found. Phthalate exposure has been reported to 97 shorten the anogenital distance of infants (Bornehag et al., 2015; Swan et al., 2005; Swan et al., 2015) . 98 The associations between phthalates exposure and neurodevelopment and childhood obesity were also 99 9 143 Methods 144
Participants 145
This study was based on the Sapporo Cohort of the Hokkaido Study on Environment and Children's 146 Health. Details of this study, regarding the population, data collection, sampling of the biological 147 specimens, and contents of the questionnaire, have been previously described (Kishi et al., 2013; 148 Kishi et al., 2011) . Briefly, native Japanese women at an obstetrics and gynecology hospital in 149 Sapporo (Hokkaido, Japan), who lived in Sapporo City or surrounding areas, were enrolled in the 150 study at 23-35 weeks of gestation between July 2002 and October 2005. Among the 1796 pregnant 151 women approached, 25% were excluded as they were enrolled in the Japanese Cord Blood Bank or 152 planned to deliver the baby at another hospital. Eventually, 514 pregnant women (28.6%) were 153 enrolled in this study. Selection of participants included in the analysis was described in our previous 154 study (Araki et al., 2014) . Briefly, of the 514 participants, 10 were excluded from the study due to 155 miscarriage, stillbirth, relocation, or voluntary withdrawal prior to delivery. A total of 493 maternal 156 blood samples were available for MEHP measurements. However, maternal blood samples collected 157 during hospitalization after delivery were excluded from this analysis due to the relatively short 158 biological half-life of DEHP. Steroid hormone measurements were available for 295 infant cord 159 blood samples. Finally, 202 samples with available MEHP and steroid hormone levels were included 160 in the statistical analysis. 
MEHP measurement 164
Maternal blood samples were obtained at the time of their hospital examination following recruitment. 165
If a blood sample could not be taken during pregnancy due to maternal anemia, a blood sample was 166 collected during hospitalization, within a week after delivery. All samples were stored at −80 °C until 167 analysis. MEHP, which is the primary metabolite of DEHP, was measured by gas 168 chromatography-mass spectrometry at Nagoya University. The methods for the preparation of samples 169 and standard solutions, and the instrumental analysis have been described previously (Araki et al., 170 2014; Jia et al., 2015) . The detection limit was 0.278 ng/mL (1 pmol/mL). MEHP levels in a tube 171 containing the same medium as the reaction vial were measured to determine background levels. To 172 exclude the possibility of environmental contamination of DEHP, glassware used for MEHP 173 measurements was heated at 200 °C for 2 h. A total of 493 maternal blood samples were analyzed for 174 MEHP levels. The coefficient of variation (CV) of MEHP measurements taken within a single day 175 was 2.0%-7.8% for 6 days, and the day-to-day CV for 6 days was 6.2%, at 5 pmol/mL of 176 concentration, as described previously (Jia et al., 2015) . 177 178
Measurement of steroid hormones 179
At the time of delivery, a blood sample was collected from the umbilical cord and stored at −80 °C 180 until analysis. Cord blood samples were available only from the children born vaginally. The 181 concentrations of adrenal androgens and glucocorticoids were measured using liquid 182 chromatography-tandem mass spectrometry (LC-MS/MS; Aska Pharma Medical Co., Ltd., Kanagawa, 183 Japan). The methods for the preparation of samples, standard solutions, and instrumental analysis 184 were described previously (Yamashita et al., 2007a; Yamashita et al., 2007b) . The mean intra-assay 185
CVs for steroid hormone measurements were as follows: DHEA, 2.1%-5.2%; androstenedione, 186 2.3%-6.8%; cortisol, 3.9%-10.9%; and cortisone, 1.3%-9.9%. The mean inter-assay CVs for steroid 187 hormones were: DHEA, 3.3%-4.6%; androstenedione, 6.6%-7.1%; cortisol, 7.6%-11.3%; and 188 cortisone: 7.8%-9.3% (Mitsui et al., 2016; Mitsui et al., 2015) . 189
190

Questionnaire and medical record 191
The participants completed a self-administered questionnaire regarding information on maternal age, 192 education level, household income, smoking and alcohol consumption during the first trimester, and 193 medical history. Medical records were obtained at delivery for information regarding pre-pregnancy 194 body mass index, pregnancy complications, parity, gestational age, infant sex, infant size, Apgar score, 195 and congenital anomalies, including hypospadias and cryptorchidism, . infant adrenal androgen and glucocorticoid levels were initially calculated using the Spearman's rank 201 correlation coefficient, followed by multivariate linear regression analysis. MEHP levels and adrenal 202 androgen and glucocorticoid concentrations were converted to a log10 scale because they did not fall 203 into a normal distribution. To evaluate whether the association between hormone and MEHP levels 204 differed between sexes, a multivariate linear regression model for all study participants was first 205 constructed with the interaction terms of hormone levels to sex and MEHP interaction. Since the 206 MEHP and sex interaction was not significant for any of the hormones (P interaction >0.05), a further 207 analysis was performed, in which both sexes were included in the same model. The interquartile range 208 (IQR) for MEHP concentrations and the least square means (LSM) and 95% confidence intervals 209 (CIs) for hormone levels were calculated. To calculate a p-value for the trend, linear contrast 210 coefficients of -3, -1, +1, and +3 were assigned to 1 st , 2 nd , 3 rd , and 4 th quartiles, respectively (Goudarzi 211 et al., 2016; Itoh et al., 2016) . The 1 st quartile was compared to the 2 nd , 3 rd , and 4 th quartile MEHP, and 212 the p-values were adjusted using the Bonferroni correction. When the levels were below the detection 213 limits, half of their values were used for individual hormones. Inclusion of covariates was based on 214 biological considerations, and included maternal age (continuous), maternal smoking during 215 pregnancy (yes or no), maternal alcohol consumption during pregnancy (yes or no), gestational age 216 (continuous), the week of gestation at which blood samples were taken (continuous), infant sex (boy 217 or girl), and Apgar score (ordinal variable). A previous report from our cohort population 13 demonstrated that prenatal perfluorooctane sulfonate (PFOS) levels were associated with steroid 219 hormone levels (Goudarzi et al., 2016; Itoh et al., 2016) . Therefore, PFOS was also included in the 220 adjusted model. All statistical analyses were performed using JMP Clinical 5.0 software (SAS 221 Institute Inc., NC, USA). The characteristics of the participants included in this study are shown in Supplemental Table S1 . 231
Briefly, mean ± standard deviation maternal age at delivery (years) was 29.8 ± 4.9, and 54.5% were 232 primiparous. For infants, the proportion of the boys was 46.0%, mean gestational age was 39.5 ± 1.0 233 weeks, and birth weight was 3138.6 ± 331.3 g. Apgar score at one minute after birth was nine for 234 82.7% children. Concentrations of MEHP in all samples were above the detection limit, and the 235 median (IQR) concentration was 10.4 ng/mL (5.88-15.3 ng/mL). The concentration of MEHP was not 236 significantly associated with any maternal or infant characteristics. 14 The adrenal androgen and glucocorticoid levels in infants are shown in Table 1 . DHEA levels 238 were significantly higher in girls than in boys. Correlations between MEHP levels and adrenal 239 androgen and glucocorticoid concentrations are shown in Table 2 , and the results of the linear 240 regression after adjusting for potential confounders are shown in Table 3 . MEHP levels were inversely 241 associated with cortisol and cortisone levels and glucocorticoid/adrenal androgen ratio, but positively 242 associated with DHEA levels and DHEA/androstenedione ratios. 243
The associations between MEHP and adrenal androgen and cortisol levels were analyzed for 244 potential non-linear relationships. The LSM for each hormone in each MEHP quartile is shown in 245 Figure 1 , with details of the data in Supplemental Table S2 . The adjusted LSM adrenal androgen and 246 cortisol levels in relation to the MEHP quartile showed a significant p-value trend for cortisol and 247 cortisone levels, cortisol/cortisone ratio, and glucocorticoid/adrenal androgen ratio. When comparing 248 the LSM in the 4 th quartile of MEHP with those in the 1 st quartile, cortisol and cortisone 249 concentrations and glucocorticoid/adrenal androgen ratio were decreased, whereas 250 DHEA/androstenedione and cortisol/cortisone ratios were increased. 251
Since there were significant differences in DHEA levels in the cord blood with respect to sex, 252 the associations between MEHP levels and DHEA concentrations were examined separately in boys 253 and girls for both, linear and quartile models. However, there was no association found between
Discussion 257
We have investigated the associations between maternal MEHP levels and cord blood adrenal 258 androgens (DHEA and androstenedione) and glucocorticoids (cortisol and cortisone) in mother-infant 259 pairs of a prospective birth cohort. Our results demonstrated a significant association between 260 increased maternal MEHP levels and decreased levels of cortisol and cortisone levels and 261 glucocorticoid/adrenal androgen ratio, and increased DHEA/androstenedione ratio in linear models. In 262 quartile models, p-values for trends were statistically significant for cortisol and cortisone levels, and 263 cortisol/cortisone and glucocorticoid/adrenal/androgen ratios. However, in the 4 th quartile of MEHP, 264 cortisol and cortisone levels, glucocorticoid/adrenal androgen ratio were significantly lower, and 265 DHEA/androstenedione and cortisol/cortisone ratios were significantly higher compared with the 1 st 266 quartile of MEHP. We have previously reported that increased maternal MEHP levels decreased 267 progesterone levels and testosterone/estradiol (T/E2) ratio in the cord blood (Araki et al., 2014) . In 268 combination, the study provided novel evidence regarding the effects of prenatal DEHP exposure on 269 steroidogenesis disruption in infants, and a threshold for such effects was found. 270
In previous studies, we demonstrated that PFOS levels were inversely associated with 271 progesterone, T/E2 ratio, cortisol, and cortisone, and positively associated with DHEA (Goudarzi et 272 al., 2016; Itoh et al., 2016) . Nuclear receptors, including peroxisome proliferator-activated receptor 273 (PPAR) alpha and gamma, are essential regulators of steroidogenesis, and both PFOS and DEHP are 274 known ligands of these receptors (Lovekamp-Swan et al., 2003; Vanden Heuvel et al., 2006) . Thus, 275 the effects of PFOS and DEHP exposure on steroidogenesis could overlap. In addition, there was a 276 statistically significance correlation between PFOS and MEHP (Spearman's rho = 0.453, P < 0.001). 277 Therefore, we performed a mutual adjustment with PFOS so that the changes of steroid hormone 278 levels by MEHP in this study were independent of the effect of PFOS. For further assessment, as an 279 indicator of infant stress at birth, we have included the Apgar score (one minute after birth, ordinal 280 variable) into the adjusted model and the results remained consistent ( Supplemental Table S3 ). 281 Therefore, stress of the birth process cannot be a confounder in our study. 282
Previous studies examining the effects of exposure to DEHP on adrenal androgen and 283 glucocorticoids in humans are limited. A Danish pregnancy-screening biobank study, which consisted 284 of cases of cryptorchidism and hypospadias and control boys, reported that increased levels of mono 285
(2-ethyl-5-carboxypentyl) phthalate, another metabolite of DEHP, was associated with higher levels of 286 androstenedione and cortisol in the second trimester amniotic fluid (Jensen et al., 2015) . Further, a 287 statistically significant association between DEHP metabolites and hormones seemed more strongly in 288 cases than controls (Jensen et al., 2015) . However, increased MEHP levels in the present study were 289 associated with reduced androstenedione and cortisol levels, although the p-values did not reach 290 statistically significant levels. Steroid hormone levels shift during the gestational period, such that the 291 inconsistent results could be due to the timing of the steroid measurements (Kuijper et al., 2013) . In 292 addition, there were no cases of cryptorchidism or hypospadias in present study. Thus, difference of 293 the study participants could be another reason for the inconsistencies of the results. 294 This is the first study that examined MEHP exposure and DHEA levels at birth, and reported 295 that MEHP levels were inversely associated with DHEA levels in a linear model. In birth cohort 296 studies in Mexico, DHEA-S levels were increased and decreased in pubescent boys and girls, 297 respectively, following prenatal phthalate exposure (Ferguson et al., 2014; Watkins et al., 2014) . 298 Mouristen et al.(2013) reported the results of a prospective cohort study in Denmark, in which 299 phthalate levels in the urine of children were inversely associated with the DHEA-S levels in both 300 sexes (Mouritsen et al., 2013) . These studies in Mexico and Denmark measured hormone levels in 301 children at puberty, whereas the present study measured hormones at birth. Another explanation for 302 the inconsistencies between the results of this study and those of previous studies is that 303 instead of DHEA, was measured in the Mexico and Denmark studies. The levels of a DHEA 304 sulfotransferase family 2A member 1 (SULT2A1), which converts DHEA to DHEA-S, were reported 305 to be downregulated by phthalates in a previous study (Harris et al., 2007) . Therefore, the effects of 306 DEHP exposure on the levels of DHEA and DHEA-S could differ. 307
The findings of this study could be explained by previous experimental studies as shown in 308 Figure 2 . Decreased levels of progesterone following DEHP exposure likely resulted from the 309 downregulation of hydroxy-delta-5-steroid dehydrogenase, 3 beta-and steroid delta-isomerase 1 310 (HSD3B1). Similarly, increases in the DHEA levels and DHEA/androstenedione ratio could also 311 result from the downregulation of HSD3B1. Increased cortisol/cortisone ratios could be due to 312 DEHP-mediated downregulation of hydroxysteroid 11-beta dehydrogenase 2 (HSD11B2). Finally, decreased levels of cortisol and cortisone, together with a reduced glucocorticoid/adrenal androgen 314 ratio, could be due to a shift of steroidogenesis from glucocorticoids to adrenal androgen by 315 downregulation of HSD3B1 and hydroxysteroid 17-beta dehydrogenase 1 (HSD17B1). Additionally, 316 cholesterol is a substrate of whole steroid hormones. Thus, changes in the cholesterol profile 317 following exposure to DEHP may exist as demonstrated in a previous study of elderly patients in 318 which reduced levels of cholesterol were detected following DEHP exposure (Olsén et al., 2012) . and doses that are not relevant for the human exposure scenario. Moreover, the changes in gene 332 expression of steroidogenic enzymes may vary significantly depending on the experimental conditions, 333 such as cell lines, species, doses, timing, and duration of exposure. (Akingbemin et al., 2001 (Akingbemin et al., , 2004 334 As we described in our previous study (Araki et al., 2014) , the levels of MEHP in this cohort 336 were slightly higher than those in American adults (NHANES 1999 (NHANES -2000 , elderly Swedish subjects, 337 and pregnant women in Australia (Hart et al., 2014; Lind et al., 2012; Silva et al., 2004) . Slightly 338 higher MEHP levels in this study can be considered acceptable as the levels of DEHP in house dust in 339 Sapporo, Japan were higher compared with the studies from other countries, and DEHP intake in the 340 Japanese population was higher than that of most other studies (Ait Bamai et al., 2014; Ait Bamai et 341 al., 2015) . On the other hand, as for the first limitation, it should be also noted that MEHP in blood 342 was measured as urine samples were not available in this study. All samples were handled carefully to 343 avoid ex vivo hydrolysis of DEHP; therefore, measurement errors due to contamination were minimal 344 (Araki et al., 2014 ) . Nevertheless, mono (2-ethyl-5-carboxypentyl) phthalate and mono 345
(2-ethyl-5-hydroxyhexyl) phthalate have previously been detected in maternal serum (Hart et al., 346 2014); thus, these secondary metabolites should be measured in future studies. 347
Another limitation of this study was that the MEHP level was measured only once from 348 second to third trimester. However, although there are contradicting discussions regarding this in the 349 literature, several previous reports have found that single measurements can be useful (Hoppin et al., 350 2002; Townsend et al., 2013) . In addition, the blood sampling week was adjusted to minimize the 351 effect of timing of exposure in this study. Although, we cannot rule out a possibility of the effect from 352 acute exposure before delivery at the hospital, non-differential errors bias an effect towards the null. 353 In this study, all participants who delivered vaginally with available cord blood samples were included 354 in the analysis. Compared to the initial cohort population, the infants had an increased gestational age 355 and heavier birth weight than those who were excluded from the study. As a result, healthier infants 356 were included in the analysis; thus, the effects of MEHP may be underestimated in this study. In 357 addition, the participation rate in our cohort study is rather low, which may limit the extrapolation of 358 our results to the general population. Finally, the observation of only minimal reductions in the levels 359 of cortisol in the linear model (0.1 > P > 0.05) may have been due to the limited sample size. Future 360 studies with larger sample sizes are then required to confirm the results. A major strength of the 361 present study is that this has a prospective birth cohort design, in which the effects of prenatal DEHP 362 exposure on fetal adrenal androgen and glucocorticoids could be estimated. In addition, steroid 363 hormones were measured by LC-MS/MS methods, which are considered more accurate than other 364 methods, such as radioimmunoassay. 365 366
Conclusion 367
In summary, this study found significant associations between increased maternal MEHP levels and 368 reduced cortisol and cortisone levels and glucocorticoid/adrenal androgen ratio and increased reduced progesterone levels (Araki et al., 2014 ) , the present results suggested that prenatal DEHP 371 exposure disrupted the steroid hormone profile of infants, despite the levels of DEHP in the general 372 population being markedly lower than those in experimental studies. Disrupting the balance of steroid 373 hormones may cause adverse effects on reproductive growth, development, and other health outcomes 374 in later life. The clinical significance of these findings is unclear at present because it remains 375 unknown whether these small hormonal alterations exert any effect on health. 376 377 Acknowledgements 378
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